Tag: WETF

Finance

Stocks In News: Dollar General Corp. (NYSE:DG), Arcos Dorados Holding Inc (NYSE:ARCO), WisdomTree Investments, Inc. (NASDAQ:WETF), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Dollar General Corp. (NYSE:DG), a rival chain, has said it’s not interested in a merger with Family Dollar. And Wal-Mart wouldn’t have much use for the company’s stores because they’re too small for its Express format, Montagna said. Dollar General Corp. (NYSE:DG) stock performance was 7.35% in last session and finished the day at $62.25. Traded volume was 25.42million shares in the last session and … Continue reading Stocks In News: Dollar General Corp. (NYSE:DG), Arcos Dorados Holding Inc (NYSE:ARCO), WisdomTree Investments, Inc. (NASDAQ:WETF), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Jayne Crisman
Finance

Stocks Getting Investor’s Attention: Arena Pharmaceuticals (NASDAQ:ARNA), Oasis Petroleum (NYSE:OAS), The Royal Bank of Scotland (NYSE:RBS), WisdomTree Investments (NASDAQ:WETF), BPT

On Jan 08, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced encouraging top-line results from a phase Ib study (n=50) on APD334 being developed for the treatment of autoimmune diseases. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is 51.25%. On last trading day company shares ended up $5.43. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is 31.40%. Hedge fund SPO … Continue reading Stocks Getting Investor’s Attention: Arena Pharmaceuticals (NASDAQ:ARNA), Oasis Petroleum (NYSE:OAS), The Royal Bank of Scotland (NYSE:RBS), WisdomTree Investments (NASDAQ:WETF), BPT

Chris Lewis
Finance

Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Insys Therapeutics, Inc. (NASDAQ:INSY) announced that the FDA has granted orphan drug status to its pharmaceutical cannabidiol (CBD), for the treatment of glioblastoma multiforme (GBM.V). Glioblastoma multiforme is the most common and aggressive form of malignant primary brain tumor. INSYS Therapeutics, Inc. (NASDAQ:INSY) belongs to Healthcare sector. Its net profit margin is 31.70% and weekly performance is -4.03%. On last trading day company shares ended … Continue reading Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Jason Knox